MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Visuospatial deficits characterize Pisa syndrome and not Camptocormia in Parkinson’s disease

CA. Artusi, E. Montanaro, R. Erro, N. Margraf, C. Geroin, F. Spagnolo, A. Pilotto, L. Magistrelli, A. Marchet, M. Zibetti, C. Comi, A. Padovani, M. Tinazzi, L. Lopiano (Torino, Italy)

Meeting: 2022 International Congress

Abstract Number: 1202

Keywords: Pisa syndrome, Posture, Visuospatial deficits

Category: Parkinson's Disease: Cognitive functions

Objective: We performed a multicenter, case-control study with the aim to analyze cognitive differences between parkinsonian patients with Pisa syndrome or camptocormia and matched controls with Parkinson’s disease (PD) without postural abnormalities (PA).

Background: Pisa syndrome and camptocormia are frequent complications of the PD clinical picture. The pathophysiology of these PA remains unclear, but the role of cognitive deficits has been postulated in pilot studies with small sample size.

Method: We performed a case-control study involving 7 Italian and 1 German Movement Disorders centers assessing demographic, clinical, and cognitive features of 114 PD patients: 32 with Pisa syndrome (PS+), 25 with camptocormia (CC+), 32 PD patients matched with PS+ patients for gender, age, level of education, PD duration, and PD stage (PS-), and 25 PD patients matched with CC+ patients for the same features (CC-).
A comprehensive neuropsychological battery was used to assess memory, attention, executive functions, visuospatial abilities, and language. The z-score, a numeric value obtained from the comparison between the patient’s raw score and the mean obtained by a group of healthy subjects from the same country, was used for each test and for the calculation of a cognitive domain score, and compared between groups using the Mann-Whitney U test.

Results: All groups were comparable for the main demographic and clinical features. Regarding cognition, PS+ patients showed significantly worse visuospatial performances than PS- (-1.29 – 95%IC -1.80, 0.01 – vs. -0.54 – 95%IC -0.97, 0.13 – p = 0.02), while CC+ did not show significant differences compared to CC-. The global cognitive assessment (MoCA) did not differ significantly between groups, nor did the scores regarding memory, executive functions, and language domains.

Conclusion: Our findings confirm preliminary data on the association of worse visuospatial abilities in PD patients with PS compared with PD patients without PA but with the same age, disease duration, and disease stage and characteristics. Moreover, we observed that patients with camptocormia did not have the same association, pointing toward different underlying pathophysiology between Pisa syndrome and camptocormia, with specific cognitive deficits related to visual-spatial abilities possibly implicated in the development of Pisa syndrome.

To cite this abstract in AMA style:

CA. Artusi, E. Montanaro, R. Erro, N. Margraf, C. Geroin, F. Spagnolo, A. Pilotto, L. Magistrelli, A. Marchet, M. Zibetti, C. Comi, A. Padovani, M. Tinazzi, L. Lopiano. Visuospatial deficits characterize Pisa syndrome and not Camptocormia in Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/visuospatial-deficits-characterize-pisa-syndrome-and-not-camptocormia-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/visuospatial-deficits-characterize-pisa-syndrome-and-not-camptocormia-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley